Actively Recruiting
Preventive Catheter Ablation to Treat Ventricular Arrhythmias in Adults with End-Stage Heart Failure Evaluated for Heart Transplant
Led by Heart and Diabetes Center North-Rhine Westfalia · Updated on 2024-12-04
160
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating preventive catheter ablation as a treatment for patients with ischemic cardiomyopathy and end-stage heart failure who are being considered for heart transplantation. This study compares catheter ablation therapy with optimal medical treatment to assess their effects on survival, heart failure progression, and other clinical outcomes. The trial involves adult patients with severe heart dysfunction and arrhythmias and follows them over an average of two years.
CONDITIONS
Brief Title
Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure
Research Team
C
Christian Sohns, MD
A
Astrid Kleemeyer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
